Innovative stroke risk treatment
Huntington Hospital is the only facility in the San Gabriel Valley to offer
the FDA-approved WATCHMAN™ Left Atrial Appendage Closure (LAAC)
device for patients with atrial fibrillation (AFib) as an alternative
to the lifelong use of warfarin or Novel Oral Anticoagulants (NOAC) for
people with AFib not caused by a heart valve problem (also known as non-valvular AFib).
Learn more about WATCHMAN at Huntington Hospital in our press release.
“The WATCHMAN device is a novel alternative for patients with non-valvular
AFib at risk for a stroke, especially those with a compelling reason not
to be on blood thinners. We provide over 2,000 catheterizations and electrophysiology
procedures, and 42,000 non-invasive cardiac diagnostic procedures each
year. I’m proud to now offer this safe and effective procedure to
our patients seeking stroke risk treatment."
- Alex Durairaj, MD, medical director of Cardiovascular Services, Huntington
WATCHMAN Patient Resources
Download these information guides to learn more about WATCHMAN, Atrial
Fibrillation and how to talk to your doctor about the best way to minimize
your stroke risk.
Get the Patient Guide
Get the AFib Guide
Get the Doctor Discussion Guide
For more information on the WATCHMAN device, please visit:
Find a WATCHMAN surgeon at Huntington Hospital
The following two surgeons at Huntington Hospital are FDA and CMS qualified
to perform WATCHMAN device implant surgeries.